Background
•Trials involving reductions in cancer treatment, particularly chemotherapy, are a growing trend
•The hope is that eliminating/reducing drug(s) will reduce toxicity burden and increase QOL without increasing recurrence or death
•Large well-designed clinical trials are needed to ensure the hope becomes a reality

Objective
•Understand consumer perceptions to inform design and communications that enhance accrual

Methodology
Qualitative study including 5 online focus groups, in April/May 2020